Changsha, China

Ming Zhao

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Inflammatory Skin Disease Treatment by Ming Zhao

Introduction

Ming Zhao is a prominent inventor based in Changsha, China. He has made significant contributions to the field of medical research, particularly in the treatment of inflammatory skin diseases. His innovative approach has led to the development of a unique therapeutic strategy that addresses the underlying mechanisms of these conditions.

Latest Patents

Ming Zhao holds a patent titled "Application of microRNA-210 inhibitor in preparation of drugs for treating inflammatory skin diseases." This patent discloses methods for utilizing a microRNA-210 inhibitor to create drugs aimed at treating inflammatory skin diseases. Through extensive experimentation, Zhao has demonstrated that inhibiting microRNA-210 expression can significantly enhance the expression of its target gene, STAT6. This process inhibits the proliferation and chemokine CCL20 secretion of keratinocytes, which further reduces T cell migration towards skin lesions and inhibits the differentiation of T1 and T17 cells. His research indicates that microRNA-210 knockout and intradermal injection of a microRNA-210 inhibitor can significantly mitigate skin inflammation in mice, providing a new pathophysiological mechanism and strategy for drug preparation in treating inflammatory skin diseases.

Career Highlights

Ming Zhao has worked at notable institutions, including the Second Xiangya Hospital of Central South University and the University of Michigan. His experience in these prestigious organizations has contributed to his expertise in medical research and innovation.

Collaborations

Ming Zhao has collaborated with esteemed colleagues such as Qianjin Lu and Yuwen Su. Their joint efforts have further advanced the research and development of treatments for inflammatory skin diseases.

Conclusion

Ming Zhao's innovative work in the field of inflammatory skin disease treatment showcases the potential of microRNA inhibitors in medical applications. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…